Tour

A Perplexing Marijuana Side Effect Relieved by Hot Showers

A new study has found that a perplexing marijuana side effect is relieved by a simple hot shower. This bizarre side effect is related to chronic hepatitis syndrome, which is marked by severe nausea and abdominal pain. Heavy marijuana users often experience nausea and vomiting, and they often take a hot shower to ease the symptoms. Although the syndrome was first recognized in 2004, U.S. doctors have been reporting it more frequently in recent years.

This cannabinoid hyperemesis syndrome is a potentially dangerous side effect of marijuana use. The condition can cause repeated bouts of nausea, vomiting, and abdominal pain. Hot showers can alleviate these symptoms, but semi femminizzati only temporarily. The side effect is thought to be caused by the drug's effects on the body. The drug has several active substances, including THC and related chemicals, which bind to certain molecules in the brain. These substances induce the drug's "high" and other effects.

The effects of cannabis use can be very serious. It can also lead to acute kidney damage. It is often not diagnosed until a patient has been using marijuana for years. But despite the severity of the side effect, the cause of it is still unknown, although it has been linked to a hot shower. Taking a hot shower is one of the easiest ways to relieve the condition.

A hot shower may be the best cure for nausea caused by marijuana. Regular hot showers can reduce this side effect and alleviate your pain. The warm water in a shower will divert blood from your gut to your skin. The body's temperature changes may also help regulate homeostasis pathways. This can lead to the relief of nausea and vomiting. This is an extremely cannabis terapeutica la normativa italiana unusual side effect of marijuana, and one that should be looked into further.

A hot shower may help people with this perplexing marijuana side effect. In a study by Allen and colleagues, a patient with this ailment admitted to taking cannabis every day since the age of 14. The patient's condition was initially misdiagnosed three times, but the hot shower relieved the symptoms. But a hot water bath may not be the best cure for this type of nausea.

The treatment for this condition is to quit marijuana. It is difficult to quit cannabis, but it does not cause the nausea. Patients with this disorder are able to recover, and their nausea has disappeared. They no longer need to take hot showers and have regained their lost body weight. But it's important to remember that the side effects of marijuana are often difficult to treat and recurrent.

This side effect may be due to the antiemetic properties of marijuana. Despite this, it is a paradoxical side effect, largely due to the fact that it causes nausea and vomiting. Hence, a hot shower is an effective solution for this condition. A hot shower relieves nausea and vomiting, which are both common conditions associated with marijuana. It may also help patients with cancer.

This side effect is unrelated to marijuana. The symptoms of CHS are related to the antiemetic effects of cannabis, but the cause of the disorder is still unknown. Symptoms of CHS may be caused by the effects of marijuana, and the symptoms of the disease may be triggered by the effects of the drug. The drug isn't recommended for pregnant women.

A perplexing marijuana side effect relieved by hot showers: Some people experience CHS symptoms, which are similar to the symptoms of allergies. The condition is accompanied by vomiting. The symptoms usually last for 24 to 48 hours. Some people may experience abdominal pain, morning nausea, and fear of vomiting. Other people may feel compelled to take a hot shower.

Epidiolex - FDA Advisory Panel Recommends Approval of Epilepsy Drug Derived From Marijuana

Expert advisory panel recommendations aren't binding on the FDA, but it typically follows the advice of the panel, and the agency's decision is expected by late June. But the Panel does recommend that the FDA approve an epilepsy drug derived from marijuana. The new medicine would be restricted to the most difficult-to-treat types of epilepsy, and doctors would be able to closely monitor patients for liver damage.

The Panel unanimously recommended FDA approval of Epidiolex, an oral solution for severe epilepsy. It found that the potential benefits outweighed the risks. The drug is intended for a small group of patients with severe cases of epilepsy. It is not the first time that the FDA has approved synthetic versions of cannabinoid chemicals in the marijuana plant, and a number of similar drugs graine féminisée floraison rapide have been approved. The cannabis chemical in question, cannabidiol, is one of over 80 active cannabinoids. Unlike THC, it does not produce a high.

The FDA's advisory panel backed Epidiolex, a prescription medication made from cannabidiol, which could be a groundbreaking treatment for rare types of epilepsy. The drug is designed to treat patients with lennox-Gastaut syndrome, which involves multiple types of seizures, as well as people with infantile spasms. The Panel recommends that the FDA approve Epidiolex by the end of June.

The panel's recommendations could have major consequences on insurance coverage and the availability of medical marijuana in the United States. This new treatment, called Epidiolex, is the first FDA-approved epilepsy drug derived from marijuana. Its creators developed it for people with rare and severe epilepsy. It is a pure form of cannabidiol, which is not psychoactive.

The FDA has recommended approval of Epidiolex, a cannabinoid-based medicine, as a treatment for children with multiple types of epilepsy. The drug is intended to treat both Lennox-Gastaut syndrome and infantile spasms. If it is approved by the FDA, it will be the first cannabis-derived medicine in the U.S., making it the most widely used cannabis-derived drug in the world.

The FDA advisory committee unanimously recommended the approval of Epidiolex, Cannabis entre vice et vertu a marijuana-derived medication for two rare forms of epilepsy. The drug's approval would be the first of its kind in the country, but the FDA can still leave cannabis at Schedule 1 if it does not find enough evidence that it can prove its value as a treatment for these two epilepsy types.

The FDA advisory committee unanimously recommended the approval of Epidiolex, an epilepsy drug derived from marijuana, as a treatment for two rare forms of epilepsy. The FDA has approved several marijuana-based products, including Marinol, which is prescribed to treat nausea and severe appetite loss in AIDS. The Centers for Disease Control and Prevention reported that more than three million adults suffer from epilepsy in the U.S.

The FDA has approved several marijuana-derived products, including Marinol, which is used to treat severe appetite loss and nausea caused by AIDS. The DEA has rescheduled Epidiolex to Schedule V, which makes it easy to get a prescription in all 50 states. The drug's approval also helps patients with other types of epilepsy, which is often difficult to treat.

Despite the controversy over the use of marijuana, the FDA has approved many marijuana-derived products. One of these is Marinol, a synthetic formulation that is currently used to treat severe appetite loss in AIDS patients. The drug is not a legal recreational product, and it is not available in dispensaries in the U.S., but it will likely be used in the future for a variety of purposes.

The FDA expert panel's recommendation comes after careful consideration of several studies. The panel recommended that the FDA approve Epidiolex, a drug derived from marijuana, as a treatment for two rare types of epilepsy. This drug is a pharmaceutical-grade version of cannabidiol, a chemical found in the cannabis plant. It is used in the treatment of seizures caused by Lennox-Gastaut syndrome and Dravet syndrome.

The Best Weed Strains in the World

There are many factors to consider when determining the best weed strains, including personal preference, historical significance, and more. However, there are certain varieties that rise above the rest and have helped shape the modern marijuana market. Let's take a closer look at some of the most popular marijuana strains in the world. This article was originally published on Weedmaps. It contains in-depth analysis of the best weed strains.

Alien Abduction: With a high THC content of approximately 17%, this strain is known for its righteous head buzz and body high. With sleep-aid and appetite-stimulant properties, this weed strain has become a popular choice. AK-47: This lovable strain is popular in medical cannabis. Its strong scent is reminiscent of a berry. Its high THC level makes it perfect for daytime use.

Mimosa: This Sativa-dominant hybrid was developed from the cross of Purple Punch and Clementine. It is best consumed early in the morning, as it helps users relax and unwind from a stressful day. It contains about 27% THC. semillas autoflorecientes baratas . This weed strain has many benefits, and is a popular choice among recreational and medical marijuana users. It is also beneficial for people who suffer from anxiety, depression, and mood swings.

Chocolope: If you're looking for a morning toke, this cannabis hybrid is a must-have. Its aroma is a mix of chocolate and coffee, perfect for the morning toke. It has an earthy and sweet smell and is a classic indica couchlock. It's also great for treating pain, nausea, and depression. This is a strain that's perfect for all-around health.

The top-selling strains in the United States are those with high THC levels. The top-selling strains in the world are mostly indica. The best weed for medical use is a hybrid of OG Kush and G13. OG Kush has been used by many generations since ancient times to alleviate pain. Its strong aroma will lift your mood and ease stress. Indicas are also good for medicinal purposes.

Purple Haze is a well-balanced hybrid weed strain that was developed by crossing Grapefruit and Grape Ape. The Zkittlez's THC level is around 15% and 1% CBD Marihuana medicinal . It gives users a calming effect and a high. The flavor profile is citrusy and is suitable for medicinal use. Its THC content is about 20%. These are just a few of the best weed strains for medical purposes.

Tangie is a tropical strain with a sweet, citrus-like aroma. This hybrid is a cross between a California orange and a Skunk. Its THC content is around 15% and 1% CBD. The Zkittlez is a great all-around strain that can relieve anxiety and chronic pain. One of the best weed strains for medicinal purposes is called Purple Haze. It is a cross between Purple Thai and haze. It has a THC level of 14-26%.

Acapulco Gold is a sativa-dominant strain that is redolent with sweet, citrus, and earthy flavors. It is an indica-sativa hybrid that is perfect for medicinal use. Its THC level is around 15%, and it has about 1% CBD. It is also an indica-dominant hybrid, but it has a sweet citrus candy taste.

Aside from the best THC-CBD ratios, cannabis can produce hundreds of different strains. Some of the best weed strains are Sativa-dominant and contain high THC levels of 14-26%. While the THC levels in these two strains vary, each one has a distinct taste and aroma. In addition, each strain is unique. There are some that have a high CBD content of 0.3% and low THC.

Durban Poison is a pure sativa strain that was created by crossing Mexican and Thai genetics. It is 20 percent THC and has a euphoric head high. The Durban Poison is considered one of the best weed strains for medicinal use. Its strong THC content makes it ideal for medical patients. Its terpene profile is perfect for medicinal use.

Where Marijuana Is Legal the Opioid Prescriptions Fall

According to a new study, where marijuana is legal, opioid prescriptions fall. It's a paradox that the opioid crisis is worsening as more states become legalized. Despite the widespread legalization of cannabis, doctors have still largely ignored the potential impact of medical marijuana on the epidemic. While medical marijuana is an important tool for treating pain, the issue is far more complex than it appears.

Studies have linked the availability of cannabis dispensaries to a decrease in the number of prescriptions for opioids. When the number of dispensaries increased by just one, opioid related mortality fell by 17% or 40 percent for every 1,000 people. This association was even greater in states where both medical and recreational marijuana were legal. While the study was limited to only one state, the results were impressive and have given hope to medical professionals.

Although medical marijuana is still illegal in many areas, legalizing it in some states has shown significant reductions in prescription painkillers. After the passage of medical marijuana laws in 33 states, the number of prescriptions of opioids for Medicare and Medicaid enrollees fell by 14 percent or more per 1,000 people. This decline was even greater in states that legalized autoflowering samen both medical and recreational marijuana.

There are still many questions to be answered, but there are some promising signs. While marijuana use is becoming legal in some states, more robust studies are needed to determine whether marijuana legislation has a significant impact on the opioid epidemic. Where marijuana is legal, doctors will more likely prescribe marijuana in lieu of opioids. While research indicates that marijuana is not directly related to the rise of opioid overdoses, more robust studies are needed to make an accurate diagnosis of the long-term effects.

It is important to note that marijuana has been shown to decrease the number of opioid overdose deaths and the number of emergency room visits. Some experts have suggested that marijuana could reduce the number of overdose deaths and curb opioid addiction. But this is still a controversial topic and further research is needed. A recent study in the Journal of Public Administration found that where marijuana is legal, opioid overdoses fell dramatically and the deaths fell.

The prevalence of marijuana is lower in states with legalized medical marijuana. The drug is more widely available than ever before and more patients are getting access to it. The drug has been shown to reduce overdose deaths. There are several types of marijuana laws. Some state legislations are aimed at reducing opioid abuse. However, not all states have the same effect. While cannabis has fewer negative effects on the opioid crisis, there are varying levels of risks associated with it.

A recent study analyzed Medicaid prescription data from 2011 to 2016. The study found that states with medical marijuana laws saw a 5.88% reduction in opiate prescriptions, while states without legalization saw a 6.38% decrease in prescriptions. Further, it was also found that the number of people using cannabis for medicinal purposes was significantly lower in states that had recreational marijuana laws.

In some states, the opioid epidemic is so severe that medical marijuana has reduced the rate of opioid prescriptions. The study also noted that medical cannabis laws can reduce the risk of overdose and prevent addiction. Where legalization of marijuana is legal, the number of prescriptions has decreased by almost half. This decrease in overdose has resulted in lower hospitalization Cannabis-Branche rates and higher health care costs.

While marijuana is not a substitute for opioids, it can help people suffering from pain. While opioids remain the drug of choice for acute pain, marijuana is better for long-term and chronic conditions. It is also safer than opiates. As a result, it could reduce prescriptions and save lives. A recent Pew poll revealed that 61 percent of Americans surveyed favor legalizing marijuana.

Oklahoma Votes to Legalize Medical Marijuana

A measure allowing the sale of medical marijuana in Oklahoma was placed on the November 2016 general election ballot through an initiative petition. The campaign was led by the nonprofit group Oklahomans for Health. The initiative petition required 65,987 valid signatures to be placed on the ballot. The group filed the petition on April 11, 2016, and had until August 11 to gather the signatures. The groups verified signatures in September and hoped the measure would make it onto the November ballot.

Although the state's medical marijuana initiative failed, it did pass with a 56.8% margin. Opponents, including U.S. Sen. James Lankford, ran a television ad urging voters to reject the measure. Other groups opposed to the measure included the Oklahoma State Medical Association and the District Attorneys' Association. While the legalization campaign failed to turn out enough voters to sway the outcome, supporters were able to convince many voters to support the new law.

Opponents of the new law said it was a dangerous precedent for medical marijuana. The voters' vote is a strong sign that they support legalizing medical cannabis. The measure's passage has drawn widespread support across the country, but the question's passage in Oklahoma is an indication that more states will follow suit in the near future. Even though this is the first step toward legalization, there is still a long way to go.

A medical marijuana program in Oklahoma was approved by the state's voters on Nov. 6, 2018. However, the measure faces several challenges that are still in the works. Governor Mary Fallin fought against the legalization and endorsed it. U.S. Sen. James Lankford also aired an ad urging voters to oppose the measure. The Oklahoma State Medical Association and the District Attorneys' Association campaigned against the amendment. The question failed to pass, but the votes are a strong indicator of the future of medical marijuana in Oklahoma.

The measure passed in Oklahoma with 55.8% of the vote. In 2017, the National Academies of Sciences, Engineering, and Medicine conducted a review of marijuana research and concluded that marijuana is a promising treatment for cancer patients. The state's legislature may amend the law in the near future, but the legalization of medical marijuana has already taken effect. This is a positive sign for the state's citizens. The new law will provide more freedom for the people living in rural areas.

The state's overwhelmingly approved medical marijuana law was passed by voters in November 2016. However, opponents of the legalization of recreational marijuana feared that the initiative would allow recreational marijuana businesses to thrive in Oklahoma. While the state's legislature is still debating the issue, it has not yet formally endorsed it. The Oklahoma Legislature is continuing to address the issue, and it is a good time to start the process.

The law allows patients to obtain a medical marijuana license after a physician's recommendation. The state's new law also allows physicians to prescribe marijuana to patients who need it for serious health conditions. Unlike other states, Oklahoma has not yet made the process easy, but it has helped millions of patients who were previously denied access to medication. It is a great step forward for the entire state, and it is worth the wait.

Opponents have raised questions about the legalization of medical marijuana. While the state has a reputation for being conservative, attitudes toward marijuana have changed significantly in recent decades. It is increasingly popular among young people and is especially popular among Republicans. Despite its opposition, the new law has been welcomed by doctors. If the law is implemented, it will require a large amount of money and a large number of physicians to be licensed to legally sell marijuana.

The state's medical association and lawmakers are still studying the law. A new law would allow patients to possess up to one ounce of marijuana and grow six mature cannabis plants in their homes. It would also require a 15% tax on all sales of the drug. The revenue generated from the sale of medical marijuana would fund education programs and substance misuse treatment services. Interestingly, the new law does not include any legal marijuana-related expenses.

Molson Coors Turns to Marijuana As Beer Sales Drop

A year after first-quarter sales fell 5.8% in the U.S. and operating profit missed estimates, Molson Coors is turning to marijuana to recoup losses. The Canadian brewer is partnering with a marijuana company to develop a line of nonalcoholic cannabis drinks. The decision to venture into the cannabis industry is an interesting one for the brewing giant, which has struggled in recent years to increase beer sales.

While the U.S. marijuana industry has experienced its fair share of volatility, Molson Coors has not yet felt any significant impact. The company has made a deal with a Canadian cannabis producer to develop a new line of non-alcoholic cannabis-infused beverages. In Canada, the company plans to launch a portfolio of cannabis-infused beverages when the drug is legal there.

While the Canadian government is not yet fully legalizing marijuana autoflowers zaden , Molson Coors is looking at a new business opportunity with this emerging market. As cannabis becomes more widely available, the company plans to partner with Canadian pot companies to develop non-alcoholic products. Its plans involve a cannabis-infused beverage. The challenge will be getting the FDA to approve these products. This is because the company is concerned about people's health, not about profits.

The Canadian legalization of marijuana presents a huge opportunity for Molson Coors. The company will partner with the new industry and develop products to appeal to the cannabis consumer. Creating and distributing these products will require a deep understanding of the laws and logistics. A partnership between the two companies will allow both companies to capitalize on the new market. Ultimately, the move could benefit both companies.

Despite the growing trend in marijuana, Molson Coors isn't the only major brewery to turn to the cannabis industry. The cannabis industry has many challenges to face, but with the help of pioneers, it will flourish. Its breweries have to be responsible with the privilege of legalization. As the company turns to marijuana, it will set a standard for future legalization in the U.S., Canada, and the rest of the world.

The Canadian legalization of marijuana has lowered beer sales and has been in decline for more than a decade. But the Canadian legalization of marijuana has changed that. With more adults enjoying it, Molson Coors' strategy of expanding into cannabis products will increase its market share. But the company must also be careful, as the combination of the two industries will bring risks.

The brewer is betting that marijuana will grow in Canada and it wants to enter the cannabis market as a way to expand its market in the U.S. The Canadian legalization of cannabis has helped Molson Coors become the No. 2 brewing company in the country. The company recently formed a joint venture with a Canadian marijuana producer to make cannabis-infused nonalcoholic beverages for the Canadian market.

Earlier this year, Molson Coors invested in L.A. Libations, a Canadian cannabis company, to develop an alcoholic beverage. In the same year, the brewery also partnered with other companies in the industry, including Casa Komos Beverage Group, which produces the Superbird cocktail. It also has a joint venture with Hexo and has launched a nootropic drink in Colorado.

With the legalization of marijuana in Canada, Molson Coors has begun expanding its business into the cannabis industry. The company has also partnered with a Canadian marijuana-infused beverage company to develop nonalcoholic cannabis-infused drinks. The company plans to expand its operations into the cannabis market, with a focus on wine, as well. The brewing giant has begun a partnership with Hexo cannabis, wiet, hennep of hasjiesj, which aims to produce hemp-infused beverages.

A partnership with Molson Coors has brought the brewer closer to marijuana, which is an increasingly popular beverage. The beverage also brings the added benefit of health benefits. The company's rebranding of itself as the Molson Coors Beverage Company reflects its diversification. Several of the products include infused cannabis beverages, and Truss has a strong start with its new brand.

Pot Smuggling Arrests at LAX Have Sprung by 166% Since Marijuana Legalization

According to an attorney for the airport, pot smuggling arrests have doubled at LAX in the past six months. A UCLA student-athlete was arrested for having 34 grams of marijuana, which was nearly 6 grams more than the legal limit in California. The suspect apologised to the officers and was let off with a warning. Many traffickers hide and disguise large amounts of cannabis, which they disguise as candy.

The increase in the number of arrested people carrying marijuana is causing alarm among airport officials. The number of passengers bringing pot through the airport has increased by 166%. Authorities in California have noted that the amount of marijuana being checked into checked luggage has risen by more than 400 percent. The arrests also reflect the burgeoning marijuana market in the state.

The increase in arrests at LAX can be attributed to the fact that California legalized marijuana. This has allowed for a higher demand for pot. During the last year, more than 500 reports of marijuana in checked bags were made at LAX. Of these, one-fifth of the cases were involving people suspected of trafficking. Even though it's legal for recreational use in California, samonakvétací smuggling it through a federal airport is still illegal.

However, despite the recent change in policy, this increased risk to travelers is still a reality. While the numbers of smuggling arrests at LAx aren't high, the number of passengers carrying small amounts of weed has grown. While the California government has legalized marijuana, the Alameda County Sheriff's Office has seen an uptick in marijuana smuggling compared to the same period of the prior two years.

While marijuana was legalized in California, it was only recently that the state enacted new regulations concerning marijuana. Aside from California's legalization of marijuana, the airport also has a strict policy on the use of the drug. The airport police are not permitted to make an arrest if the person is following state law. Aside from the smuggling laws, the state's cannabis laws have made it illegal for the people to carry the drug.

The legalization of marijuana has also made smuggling easier. The number of arrests at LAX has increased by 166%. The law has made it easier for travelers to transport marijuana, but the legalization has also emboldened smugglers. It is now illegal to export the drug in most of the US, so the LAX has become an important hub for the illegal export of the drug.

The legalization of marijuana has increased the risks of drug smuggling. When people travel to California, they often bring small amounts of marijuana with them. As a result, the airport has become a hub for illegal exports of the drug. It is important to note that the laws that legalize marijuana do not restrict the importation of the substance.

The increase in arrests at LAX is primarily due to increased marijuana trafficking. The airport's security forces do not have the authority to arrest travelers. They have to refer any incidents of illegal activity to local law enforcement. When a passenger is caught carrying a small amount of marijuana, the airport authorities will confiscate the drug. In some cases, the drug is used to make a person feel drunk or unconscious.

After the legalization of marijuana, the marijuana industry has seen an increase in the number of passengers who carry small amounts of the drug. This has created a huge market for illegal exports. This has also led to an increase in the Konopí rumištní number of bags that are checked at LAX. Moreover, the amount of marijuana in check-in bags has risen tenfold in the last two years, resulting in a spike in the amount of drugs in the country.

The Science Behind the DEA's Long War on Marijuana

While the U.S. Department of Justice and the Food and Drug Administration advise the DEA on marijuana policy, the agency has the final say on marijuana scheduling. The DEA's decisions on the scheduling of cannabis are based on medical and scientific evaluations. The DEA, for its part, has argued that cannabis has no medical value, and that it is no more dangerous than alcohol.

While there is little scientific evidence to support the current classification, many scientists believe that legalization will lead to healthier people. The DEA's long war on marijuana THC has stalled medical progress. For example, there are fewer drugs available to treat certain illnesses and conditions than marijuana. The DEA has also argued that it has limited research opportunities. The National Institute on Drug Abuse (NIADA) says marijuana's illegal status prevents researchers from conducting the necessary tests.

In February 2018, the American Medical Association recommended that the DEA review marijuana's Schedule I status to ensure that it does not violate federal law. In addition, a 2014 Medscape survey of 1,500 physicians revealed that 56 percent of physicians support legalizing marijuana for medical purposes, with 82 percent support among responding oncologists. The DEA's stance against legalization is not backed by scientific evidence.

In fact, cannabis has no known harmful effects on humans, so research is needed to understand the benefits and harms of the drug. Moreover, if more studies are conducted, the DEA might consider legalizing the substance at federal level. Currently, the legalization of marijuana in the United States has become bigger than the organic produce industry. The demand for cannabidiol, a derivative of marijuana, is projected to be $23 billion within three years.

The DEA has been trying to make marijuana illegal since its prohibition. In spite of its legal status, marijuana has become popular in the United States. According to the study, more than one third of Americans have experimented with marijuana. Even the U.S. president has tried the drug. Furthermore, the drug is now widely accepted as harmless fun in the culture. Talk show hosts can joke about it on cable television without being deemed a criminal.

However, marijuana is not illegal in most states. The DEA's long-term war on marijuana, which began in 1937, was not based on a scientific study. It was not until the 1970s that the DEA recognized the medical value of marijuana and began automaty feminizowane arresting peddlers of the drug. But despite the DEA's long-standing policies, the peddlers were arrested.

The DEA's long war on marijuana has been fueled by anti-marijuana laws. The first federal regulation of marijuana was the Pure Food and Drug Act in 1914. In the same year, 26 states banned the drug, including Oregon. But there was no public outcry and little debate. In contrast, the American Medical Association and the Institute of Medicine recommended that the DEA review its controversial Schedule I classification of marijuana as it did not meet scientific standards.

The DEA's long war on marijuana began with a wildly inaccurate propaganda campaign against "evil weed." In 1937, Congress passed the Marijuana Tax Act, a law that criminalized the use of marijuana and limited its sale to people who had paid the tax. In the same year, the New York Academy of Medicine issued a report concluding that the drug did not cause violence and insanity. Regardless of the facts, the DEA's legalization of marijuana was based on a myth.

In addition to a lack of scientific evidence, a lack of a legitimate medical use for marijuana was a primary motivation for the DEA's anti-marijuana policies. In the past, the DEA had cited studies that demonstrated the therapeutic benefits of cannabis, such as a decrease in car accidents and the lowering of blood pressure in patients with cancer.